Cartesian Therapeutics
RNAC
RNAC
101 hedge funds and large institutions have $219M invested in Cartesian Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.06% less ownership
Funds ownership: 1.61% → 1.54% (-0.06%)
11% less capital invested
Capital invested by funds: $245M → $219M (-$26M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
101
Holding in Top 10
–
Calls
$2.89M
Puts
$635K
Top Buyers
| 1 | +$2.98M | |
| 2 | +$2.88M | |
| 3 | +$1.88M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.76M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.27M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$3.57M | |
| 3 | -$2.87M | |
| 4 |
Goldman Sachs
New York
|
-$2.14M |
| 5 |
AG
Artal Group
Luxembourg
|
-$2.09M |